Ping‐Hsien Lee
Impact in
- Oncology top 10%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Immunology top 10%
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
Papers in
-
- T-cell and B-cell Immunology 3
- Immune Cell Function and Interaction 1
- Immunotherapy and Immune Responses 1
-
- SARS-CoV-2 and COVID-19 Research 2
- Co-authors
- Nicholas P. Restifo (5 shared papers)Tori N. Yamamoto (4 shared papers)Zhiya Yu (3 shared papers)Suman Kumar Vodnala (3 shared papers)Rigel J. Kishton (3 shared papers)Robert L Eil (2 shared papers)Christopher Austin Klebanoff (2 shared papers)Madhusudhanan Sukumar (2 shared papers)
- Journals
- The Journal of Immunology (2 papers)The Journal of Experimental Medicine (2 papers)Journal of Clinical Investigation (1 paper)Immunology Letters (1 paper)Blood (1 paper)
- Partner nations
- United StatesJapanUnited Kingdom
In The Last Decade
Ping‐Hsien Lee
15 papers receiving 1.1k citations
Ping‐Hsien Lee's Hit Papers
Peers
Comparison fields: 5 of 55
- Oncology 220
- Immunology 184
- Infectious Diseases 69
- Genetics 78
- Molecular Biology 124
Countries citing papers authored by Ping‐Hsien Lee
This map shows the geographic impact of Ping‐Hsien Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping‐Hsien Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping‐Hsien Lee more than expected).
Fields of papers citing papers by Ping‐Hsien Lee
This network shows the impact of papers produced by Ping‐Hsien Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping‐Hsien Lee. The network helps show where Ping‐Hsien Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside Ping‐Hsien Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | T cell stemness and dysfunction in tumors are triggered by a common mechanism Hit paper breakdown → | 2019 | 470 |
| 2 | 2019 | 128 | |
| 3 | 2020 | 98 | |
| 4 | 2018 | 86 | |
| 5 | 2017 | 72 | |
| 6 | 2019 | 70 | |
| 7 | 2019 | 68 | |
| 8 | 2012 | 32 | |
| 9 | 2013 | 30 | |
| 10 | 2010 | 22 | |
| 11 | 2013 | 20 | |
| 12 | 2015 | 15 | |
| 13 | 2021 | 12 | |
| 14 | 2020 | 8 | |
| 15 | 2021 | 1 |
About Ping‐Hsien Lee
Ping‐Hsien Lee is a scholar working on Immunology, Infectious Diseases, Virology, Nutrition and Dietetics and Oncology, having authored 15 papers that have together received 1.1k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Genetic and Kidney Cyst Diseases (1 paper), Magnesium in Health and Disease (1 paper), CAR-T cell therapy research (1 paper), HIV Research and Treatment (1 paper), Immune Cell Function and Interaction (1 paper) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Oncology (220 citations), Immunology (184 citations), Infectious Diseases (69 citations), Genetics (78 citations) and Molecular Biology (124 citations). Ping‐Hsien Lee has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include Nicholas P. Restifo, Tori N. Yamamoto, Zhiya Yu, Suman Kumar Vodnala, Rigel J. Kishton, Robert L Eil, Christopher Austin Klebanoff, Madhusudhanan Sukumar, Ngoc‐Han Ha and Min Hwa Shin. Their work appears in journals such as The Journal of Immunology, The Journal of Experimental Medicine, Journal of Clinical Investigation, Immunology Letters and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.